Has Jason Payne, MD received payments from drug or device companies?

Yes. Drug and device makers reported $59,455 in general payments to Jason Payne, MD across 366 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jason Payne, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jason Payne, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jason Payne, MD

Clinical Cardiac Electrophysiology · Omaha, NENPI 1144420746

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (36.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 81.6% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $23,854, 4.7 times the $5,113 reported in 2019.

$59,455in general payments, 2019–2025

Across 366 payments — averaging $162.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$49K
Boston Scientific$5K
Abbott$4K
Biosense Webster, Inc.$2K
Impulse Dynamics (USA) Inc.$261
Cardiva Medical, Inc.$56
plus $16 from 1 others

$161,111in research payments, 2019–2025

Across 71 payments — averaging $2269.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$61K
Abbott$56K
Medtronic$23K
Impulse Dynamics (USA) Inc.$21K

What the payments were for

Consulting fees$2,1004%
Speaking & faculty fees$18,10130%
Travel & lodging$21,78337%
Food & beverage$17,22829%
Education$2430%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	269	$48,502
Boston Scientific	25	$5,080
Abbott	50	$3,696
Biosense Webster, Inc.	8	$1,844
Impulse Dynamics (USA) Inc.	10	$261
Cardiva Medical, Inc.	3	$56
Abiomed	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Micra$3,033
EVERA MRI XT DR SURESCAN$1,713
GENERAL - THERAPIES$1,346
Arctic Front$1,241
AFFERA MAPPING SYSTEM$1,208
ENSITE PRECISION$960
Carto 3$891
DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
AURORA EV-ICD MRI SURESCAN$734
PulseSelect$720
COBALT DR MRI SURESCAN$701
ENSITE$664
LINQ II$311
AMPLATZER PICCOLO$275
Farapulse$269
NA$249
Carto 3 System$221
AMPLATZER AMULET$155
EnSite Precision Cardiac Mapping System$155
Azure$151

How this compares

$59,455 in reported general payments places this provider in the 80th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.

See all clinical cardiac electrophysiology providers in Nebraska →

Medicare billing

Part B allowed, 2024

$185,366

Medicare patients

1,810

Services billed

3,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	245	$275,099
XareltoRivaroxaban	53	$55,790
EntrestoSacubitril/Valsartan	25	$30,754
Dofetilide	31	$5,890
Metoprolol Succinate	244	$3,745
Amiodarone Hcl	120	$3,437
Flecainide Acetate	32	$1,179
ClopidogrelClopidogrel Bisulfate	41	$419
SotalolSotalol Hcl	20	$258
Carvedilol	45	$254
Diltiazem 24hr Er (Cd)Diltiazem Hcl	13	$222
Torsemide	11	$194
Warfarin Sodium	29	$190
Losartan Potassium	31	$164
Amlodipine Besylate	31	$147

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Omaha

Hussam AbuissaOmaha$162K
Jeffrey MahoneyOmaha$118K
Shane TsaiOmaha$68K
Matthew SorensenOmaha$30K
David SternsOmaha$28K
Matthew KapalisOmaha$24K
Christopher EricksonOmaha$18K
Matthew LatachaOmaha$14K
Daniel VariOmaha$9K
John SchleiferOmaha$5K

See the full list for Nebraska →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →